A carregar...
Rituximab-induced interstitial lung disease: five case reports
Rituximab (RTX), a mouse/human chimeric anti-CD20 IgG1 monoclonal antibody has been effectively used as a single agent or in combination with chemotherapy regimen to treat lymphoma since 1997. In addition, it has been used to treat idiopathic thrombocytopenic purpura, systemic lupus erythematous, rh...
Na minha lista:
| Publicado no: | Eur Clin Respir J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Co-Action Publishing
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4629765/ https://ncbi.nlm.nih.gov/pubmed/26557260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/ecrj.v2.27178 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|